| John Penick, | |
|
1717 6th Ave S, Birmingham, AL 35233-1801 | |
| (800) 822-8816 | |
| Not Available |
| Full Name | John Penick |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 8 Years |
| Location | 1717 6th Ave S, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295199180 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 36372 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Alabama Hospital | Birmingham, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Alabama Health Services Foundation, Pc | 1951213107 | 2344 |
News Archive
Merck announced the presentation of new analyses of efficacy and safety data for investigational Cladribine Tablets in poster presentations at the Annual Meeting of the American Academy of Neurology (AAN), that took place April 22 – 28, 2017, in Boston, Massachusetts.
Researchers at Jefferson Medical College and at the Wadsworth Center in New York have identified a gene defect in mice resulting in a range of abnormalities, from cyclical hair loss and skin cancer to severe problems in normal skin development.
Today, Merck is pleased to announce its $1.5 million funding commitment over three years to the BC Centre for Excellence in HIV/AIDS (BC-CfE) in support of its research program entitled "Seek and Treat for Optimal Prevention of HIV/AIDS", known as the "seek & treat" program, which will expand HIV treatment and care for hard-to-reach residents in Prince George and Vancouver's Downtown Eastside.
A muscle relaxant called dantrolene used for treating malignant hyperthermia boosts the activity of therapies currently being developed to treat the genetic disorder Duchenne muscular dystrophy (DMD), show study findings.
› Verified 3 days ago
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
Merck announced the presentation of new analyses of efficacy and safety data for investigational Cladribine Tablets in poster presentations at the Annual Meeting of the American Academy of Neurology (AAN), that took place April 22 – 28, 2017, in Boston, Massachusetts.
Researchers at Jefferson Medical College and at the Wadsworth Center in New York have identified a gene defect in mice resulting in a range of abnormalities, from cyclical hair loss and skin cancer to severe problems in normal skin development.
Today, Merck is pleased to announce its $1.5 million funding commitment over three years to the BC Centre for Excellence in HIV/AIDS (BC-CfE) in support of its research program entitled "Seek and Treat for Optimal Prevention of HIV/AIDS", known as the "seek & treat" program, which will expand HIV treatment and care for hard-to-reach residents in Prince George and Vancouver's Downtown Eastside.
A muscle relaxant called dantrolene used for treating malignant hyperthermia boosts the activity of therapies currently being developed to treat the genetic disorder Duchenne muscular dystrophy (DMD), show study findings.
› Verified 3 days ago
| Entity Name | Oak Mountain Group Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366840761 PECOS PAC ID: 3678886256 Enrollment ID: O20150727000323 |
News Archive
Merck announced the presentation of new analyses of efficacy and safety data for investigational Cladribine Tablets in poster presentations at the Annual Meeting of the American Academy of Neurology (AAN), that took place April 22 – 28, 2017, in Boston, Massachusetts.
Researchers at Jefferson Medical College and at the Wadsworth Center in New York have identified a gene defect in mice resulting in a range of abnormalities, from cyclical hair loss and skin cancer to severe problems in normal skin development.
Today, Merck is pleased to announce its $1.5 million funding commitment over three years to the BC Centre for Excellence in HIV/AIDS (BC-CfE) in support of its research program entitled "Seek and Treat for Optimal Prevention of HIV/AIDS", known as the "seek & treat" program, which will expand HIV treatment and care for hard-to-reach residents in Prince George and Vancouver's Downtown Eastside.
A muscle relaxant called dantrolene used for treating malignant hyperthermia boosts the activity of therapies currently being developed to treat the genetic disorder Duchenne muscular dystrophy (DMD), show study findings.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Penick, 1717 6th Ave S, Birmingham, AL 35233-1801 Ph: () - | John Penick, 1717 6th Ave S, Birmingham, AL 35233-1801 Ph: (800) 822-8816 |
News Archive
Merck announced the presentation of new analyses of efficacy and safety data for investigational Cladribine Tablets in poster presentations at the Annual Meeting of the American Academy of Neurology (AAN), that took place April 22 – 28, 2017, in Boston, Massachusetts.
Researchers at Jefferson Medical College and at the Wadsworth Center in New York have identified a gene defect in mice resulting in a range of abnormalities, from cyclical hair loss and skin cancer to severe problems in normal skin development.
Today, Merck is pleased to announce its $1.5 million funding commitment over three years to the BC Centre for Excellence in HIV/AIDS (BC-CfE) in support of its research program entitled "Seek and Treat for Optimal Prevention of HIV/AIDS", known as the "seek & treat" program, which will expand HIV treatment and care for hard-to-reach residents in Prince George and Vancouver's Downtown Eastside.
A muscle relaxant called dantrolene used for treating malignant hyperthermia boosts the activity of therapies currently being developed to treat the genetic disorder Duchenne muscular dystrophy (DMD), show study findings.
› Verified 3 days ago
Carlos Aristizabal, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Birmingham, AL 35233 Phone: 205-934-4011 | |
Ronnie Mathews, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Mark Cromer, Hospitalist Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-9999 | |
Hugh Davidson Reeves, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-9666 | |
Laura Nye, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Kierstin Kennedy, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Patricia Aiken, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 |